Drug Dispensing Service

Osimertinib (Tagrisso™)

Program commencement date

June 1, 2022


Application criteria

1. Valid HKID card holder

2. Adult patients of any private hospitals or private oncology centers in Hong Kong

3. Meet the medical conditions specified by this program

4. Financial status: Family monthly income not exceeding HK$ 120,000 in total

5. Having the receipt or purchase proof of Osimertinib* and original prescription of Osimertinib issued by any Hong Kong oncologist or doctor from any Hong Kong oncology center

6. Applicants cannot concurrently accept any other Osimertinib* patient assistance program.


For the details and the application procedures of the program, please contact SafeMed Dispensary (Tel: 2979 0380).

Osimertinib's English brand name is Tagrisso